Concepts (120)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Coccidioidomycosis | 4 | 2020 | 47 | 1.29 | Why? |
| Candidiasis | 7 | 2019 | 334 | 1.28 | Why? |
| Candida | 7 | 2019 | 425 | 1.26 | Why? |
| Antifungal Agents | 9 | 2020 | 1828 | 1.23 | Why? |
| Drug Resistance, Multiple, Fungal | 5 | 2018 | 45 | 1.17 | Why? |
| Fungicides, Industrial | 1 | 2018 | 22 | 0.76 | Why? |
| Aspergillus fumigatus | 2 | 2018 | 239 | 0.76 | Why? |
| Aspergillosis | 2 | 2018 | 264 | 0.68 | Why? |
| Drug Utilization | 1 | 2018 | 619 | 0.50 | Why? |
| Environmental Exposure | 2 | 2019 | 1558 | 0.43 | Why? |
| Cholera | 1 | 2013 | 189 | 0.42 | Why? |
| Minority Groups | 1 | 2020 | 1631 | 0.40 | Why? |
| Drug Resistance, Fungal | 2 | 2019 | 191 | 0.33 | Why? |
| Azoles | 2 | 2018 | 185 | 0.32 | Why? |
| Georgia | 3 | 2021 | 955 | 0.25 | Why? |
| Health Status Disparities | 1 | 2020 | 4072 | 0.24 | Why? |
| United States | 13 | 2021 | 46150 | 0.22 | Why? |
| Vital Statistics | 1 | 2020 | 89 | 0.21 | Why? |
| Blastomycosis | 1 | 2018 | 8 | 0.19 | Why? |
| Polyenes | 1 | 2018 | 16 | 0.19 | Why? |
| Coccidioides | 1 | 2018 | 12 | 0.19 | Why? |
| Histoplasma | 1 | 2018 | 42 | 0.18 | Why? |
| Virginia | 1 | 2018 | 228 | 0.18 | Why? |
| Mutation | 1 | 2018 | 12376 | 0.18 | Why? |
| Social Welfare | 1 | 2019 | 141 | 0.17 | Why? |
| Echinocandins | 1 | 2018 | 139 | 0.17 | Why? |
| Histoplasmosis | 1 | 2018 | 83 | 0.17 | Why? |
| Microbial Sensitivity Tests | 4 | 2019 | 2886 | 0.16 | Why? |
| Young Adult | 13 | 2021 | 93724 | 0.16 | Why? |
| Cross Infection | 3 | 2019 | 8675 | 0.16 | Why? |
| Pennsylvania | 1 | 2018 | 558 | 0.16 | Why? |
| Voriconazole | 1 | 2018 | 206 | 0.16 | Why? |
| Fungi | 1 | 2019 | 471 | 0.15 | Why? |
| Cyclonic Storms | 1 | 2019 | 236 | 0.15 | Why? |
| Data Accuracy | 1 | 2021 | 715 | 0.15 | Why? |
| Microbiological Techniques | 1 | 2017 | 232 | 0.14 | Why? |
| California | 2 | 2020 | 2047 | 0.14 | Why? |
| Infectious Disease Medicine | 1 | 2018 | 311 | 0.14 | Why? |
| Endemic Diseases | 1 | 2018 | 480 | 0.14 | Why? |
| Age Distribution | 2 | 2020 | 3567 | 0.13 | Why? |
| Haiti | 1 | 2013 | 175 | 0.13 | Why? |
| Adolescent | 11 | 2021 | 86841 | 0.13 | Why? |
| Aged, 80 and over | 8 | 2021 | 88759 | 0.13 | Why? |
| Patient Acceptance of Health Care | 3 | 2021 | 5002 | 0.12 | Why? |
| Glycated Hemoglobin A | 1 | 2021 | 1316 | 0.12 | Why? |
| Aged | 12 | 2021 | 215776 | 0.12 | Why? |
| Middle Aged | 14 | 2021 | 270681 | 0.11 | Why? |
| Drug Prescriptions | 1 | 2020 | 1062 | 0.11 | Why? |
| Travel-Related Illness | 1 | 2019 | 1357 | 0.11 | Why? |
| Population Surveillance | 2 | 2018 | 4967 | 0.11 | Why? |
| Mycoses | 1 | 2017 | 589 | 0.11 | Why? |
| Disasters | 1 | 2019 | 760 | 0.10 | Why? |
| Public Health Surveillance | 2 | 2021 | 3129 | 0.10 | Why? |
| Adult | 13 | 2021 | 244371 | 0.10 | Why? |
| Ambulatory Care Facilities | 1 | 2021 | 2063 | 0.10 | Why? |
| Patient Care Management | 1 | 2021 | 1514 | 0.10 | Why? |
| Delivery of Health Care, Integrated | 1 | 2021 | 1549 | 0.10 | Why? |
| Panama | 2 | 2018 | 96 | 0.09 | Why? |
| Child, Preschool | 5 | 2020 | 36283 | 0.09 | Why? |
| Humans | 26 | 2021 | 930598 | 0.09 | Why? |
| Child | 6 | 2020 | 70012 | 0.08 | Why? |
| Communicable Diseases, Emerging | 2 | 2018 | 2523 | 0.08 | Why? |
| Risk Factors | 4 | 2021 | 71621 | 0.08 | Why? |
| Hospitalization | 4 | 2021 | 54280 | 0.08 | Why? |
| Infant | 3 | 2020 | 30274 | 0.08 | Why? |
| Male | 14 | 2021 | 367725 | 0.08 | Why? |
| International Cooperation | 1 | 2019 | 3436 | 0.07 | Why? |
| Female | 13 | 2021 | 380317 | 0.07 | Why? |
| Referral and Consultation | 1 | 2021 | 4816 | 0.07 | Why? |
| Community-Acquired Infections | 1 | 2017 | 2328 | 0.07 | Why? |
| African Americans | 1 | 2020 | 3363 | 0.07 | Why? |
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2018 | 449 | 0.07 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.06 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.06 | Why? |
| Disease Outbreaks | 4 | 2019 | 27595 | 0.06 | Why? |
| Immunocompromised Host | 1 | 2019 | 5150 | 0.06 | Why? |
| Inpatients | 1 | 2018 | 5161 | 0.06 | Why? |
| Odds Ratio | 1 | 2013 | 5861 | 0.06 | Why? |
| Age Factors | 2 | 2021 | 21039 | 0.05 | Why? |
| History, 21st Century | 2 | 2018 | 1849 | 0.05 | Why? |
| Obesity | 1 | 2021 | 7388 | 0.05 | Why? |
| Disease Management | 1 | 2018 | 6841 | 0.05 | Why? |
| Travel | 1 | 2018 | 7220 | 0.05 | Why? |
| Hypertension | 1 | 2021 | 8895 | 0.05 | Why? |
| Hospitals | 1 | 2018 | 11793 | 0.05 | Why? |
| Diabetes Mellitus | 1 | 2021 | 8207 | 0.05 | Why? |
| Anti-Bacterial Agents | 1 | 2020 | 10083 | 0.04 | Why? |
| Seroepidemiologic Studies | 1 | 2013 | 10017 | 0.04 | Why? |
| Treatment Outcome | 2 | 2021 | 51732 | 0.04 | Why? |
| Pandemics | 3 | 2020 | 389249 | 0.04 | Why? |
| Respiration, Artificial | 1 | 2021 | 22116 | 0.04 | Why? |
| Cohort Studies | 1 | 2020 | 36005 | 0.04 | Why? |
| Multimorbidity | 1 | 2021 | 703 | 0.04 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.04 | Why? |
| Invasive Fungal Infections | 1 | 2019 | 274 | 0.04 | Why? |
| Geography, Medical | 1 | 2018 | 537 | 0.04 | Why? |
| Texas | 1 | 2019 | 1237 | 0.03 | Why? |
| Candidemia | 1 | 2018 | 353 | 0.03 | Why? |
| Colombia | 1 | 2018 | 1241 | 0.03 | Why? |
| Geography | 1 | 2018 | 1801 | 0.03 | Why? |
| History, 20th Century | 1 | 2018 | 1282 | 0.03 | Why? |
| Mexico | 1 | 2019 | 2787 | 0.03 | Why? |
| New York | 1 | 2018 | 2488 | 0.03 | Why? |
| Retrospective Studies | 1 | 2021 | 105322 | 0.02 | Why? |
| Communicable Disease Control | 1 | 2017 | 29620 | 0.02 | Why? |
| Incidence | 2 | 2020 | 25622 | 0.02 | Why? |
| Risk Assessment | 2 | 2021 | 25439 | 0.02 | Why? |
| Epidemiological Monitoring | 1 | 2018 | 3493 | 0.02 | Why? |
| Ambulatory Care | 1 | 2021 | 4947 | 0.02 | Why? |
| Case-Control Studies | 1 | 2021 | 17671 | 0.01 | Why? |
| Disease Progression | 1 | 2021 | 13580 | 0.01 | Why? |
| Practice Patterns, Physicians' | 1 | 2020 | 4927 | 0.01 | Why? |
| Occupational Exposure | 1 | 2018 | 4742 | 0.01 | Why? |
| Time Factors | 1 | 2021 | 31397 | 0.01 | Why? |
| Infant, Newborn | 1 | 2018 | 23105 | 0.01 | Why? |
| Disease Transmission, Infectious | 1 | 2018 | 9044 | 0.01 | Why? |
| Global Health | 1 | 2018 | 13911 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| Intensive Care Units | 1 | 2017 | 29594 | 0.01 | Why? |
| Infection Control | 1 | 2018 | 23131 | 0.01 | Why? |
Jackson's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(120)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(146)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_